Risk factors for persistent chronic widespread pain: a community-based study

J. McBeth, Gary John MacFarlane, I. Hunt, A. J. Silman

Research output: Contribution to journalEditorial

129 Citations (Scopus)

Abstract

Background. Chronic widespread pain is the cardinal clinical feature of the fibromyalgia syndrome, which, in the majority of clinic patients, is persistent. By contrast, in community-derived patients, pain is persistent in only half of the affected individuals, particularly those with psychological distress. Whether such distress is a consequence of the pain or a manifestation of a wider process of somatization which is associated with the persistence of pain is unclear.

Objectives. We tested in a large, prospective, population-based study thr hypothesis that features of somatization predict the persistence of chronic widespread pain.

Methods. In all, 252 (13%) of 1953 adult subjects selected from a population register were classified as having chronic widespread pain based on a detailed questionnaire which included a pain drawing. Thr patients also completed a number of psychosocial instruments which measure features known to be associated with somatization. Two hundred and twenty-five (91%) of the patients were successfully followed up after 12 months and provided data on pain status using the same instruments.

Results. In all, 126 (56%) patients reported chronic widespread pain at follow-up. 74 (33%) reported other pain acid 25 (11%) reported no pain. Persistent chronic widespread pain was strongly associated with baseline test scores for high psychological distress and fatigue. In addition, these subjects were more likely to display a pattern of illness behaviour characterized by frequent visits to medical practitioners for symptoms which disrupt daily activities. The prevalence of persistent pain increased with the number of risk factors the subjects were exposed to.

Conclusions. Although almost half of the eases of chronic widespread pain resolved within 1 yr, this study has demonstrated for the first time that these subjects who display features of somatization are more likely to have widespread pain which persists. These findings have implications for the identification and treatment of poisons with persistent chronic widespread pain.

Original languageEnglish
Pages (from-to)95-101
Number of pages6
JournalRheumatology
Volume40
DOIs
Publication statusPublished - 2001

Keywords

  • chronic widespread pain
  • persistence
  • risk factors
  • somatization
  • SOMATIZATION DISORDER
  • FIBROMYALGIA SYNDROME
  • GENERAL-POPULATION
  • PREVALENCE
  • SCALES

Cite this

Risk factors for persistent chronic widespread pain: a community-based study. / McBeth, J.; MacFarlane, Gary John; Hunt, I.; Silman, A. J.

In: Rheumatology, Vol. 40, 2001, p. 95-101.

Research output: Contribution to journalEditorial

McBeth, J. ; MacFarlane, Gary John ; Hunt, I. ; Silman, A. J. / Risk factors for persistent chronic widespread pain: a community-based study. In: Rheumatology. 2001 ; Vol. 40. pp. 95-101.
@article{ba9031f92cae4042b9d389d11f7727c7,
title = "Risk factors for persistent chronic widespread pain: a community-based study",
abstract = "Background. Chronic widespread pain is the cardinal clinical feature of the fibromyalgia syndrome, which, in the majority of clinic patients, is persistent. By contrast, in community-derived patients, pain is persistent in only half of the affected individuals, particularly those with psychological distress. Whether such distress is a consequence of the pain or a manifestation of a wider process of somatization which is associated with the persistence of pain is unclear.Objectives. We tested in a large, prospective, population-based study thr hypothesis that features of somatization predict the persistence of chronic widespread pain.Methods. In all, 252 (13{\%}) of 1953 adult subjects selected from a population register were classified as having chronic widespread pain based on a detailed questionnaire which included a pain drawing. Thr patients also completed a number of psychosocial instruments which measure features known to be associated with somatization. Two hundred and twenty-five (91{\%}) of the patients were successfully followed up after 12 months and provided data on pain status using the same instruments.Results. In all, 126 (56{\%}) patients reported chronic widespread pain at follow-up. 74 (33{\%}) reported other pain acid 25 (11{\%}) reported no pain. Persistent chronic widespread pain was strongly associated with baseline test scores for high psychological distress and fatigue. In addition, these subjects were more likely to display a pattern of illness behaviour characterized by frequent visits to medical practitioners for symptoms which disrupt daily activities. The prevalence of persistent pain increased with the number of risk factors the subjects were exposed to.Conclusions. Although almost half of the eases of chronic widespread pain resolved within 1 yr, this study has demonstrated for the first time that these subjects who display features of somatization are more likely to have widespread pain which persists. These findings have implications for the identification and treatment of poisons with persistent chronic widespread pain.",
keywords = "chronic widespread pain, persistence, risk factors, somatization, SOMATIZATION DISORDER, FIBROMYALGIA SYNDROME, GENERAL-POPULATION, PREVALENCE, SCALES",
author = "J. McBeth and MacFarlane, {Gary John} and I. Hunt and Silman, {A. J.}",
year = "2001",
doi = "10.1093/rheumatology/40.1.95",
language = "English",
volume = "40",
pages = "95--101",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "OXFORD UNIV PRESS INC",

}

TY - JOUR

T1 - Risk factors for persistent chronic widespread pain: a community-based study

AU - McBeth, J.

AU - MacFarlane, Gary John

AU - Hunt, I.

AU - Silman, A. J.

PY - 2001

Y1 - 2001

N2 - Background. Chronic widespread pain is the cardinal clinical feature of the fibromyalgia syndrome, which, in the majority of clinic patients, is persistent. By contrast, in community-derived patients, pain is persistent in only half of the affected individuals, particularly those with psychological distress. Whether such distress is a consequence of the pain or a manifestation of a wider process of somatization which is associated with the persistence of pain is unclear.Objectives. We tested in a large, prospective, population-based study thr hypothesis that features of somatization predict the persistence of chronic widespread pain.Methods. In all, 252 (13%) of 1953 adult subjects selected from a population register were classified as having chronic widespread pain based on a detailed questionnaire which included a pain drawing. Thr patients also completed a number of psychosocial instruments which measure features known to be associated with somatization. Two hundred and twenty-five (91%) of the patients were successfully followed up after 12 months and provided data on pain status using the same instruments.Results. In all, 126 (56%) patients reported chronic widespread pain at follow-up. 74 (33%) reported other pain acid 25 (11%) reported no pain. Persistent chronic widespread pain was strongly associated with baseline test scores for high psychological distress and fatigue. In addition, these subjects were more likely to display a pattern of illness behaviour characterized by frequent visits to medical practitioners for symptoms which disrupt daily activities. The prevalence of persistent pain increased with the number of risk factors the subjects were exposed to.Conclusions. Although almost half of the eases of chronic widespread pain resolved within 1 yr, this study has demonstrated for the first time that these subjects who display features of somatization are more likely to have widespread pain which persists. These findings have implications for the identification and treatment of poisons with persistent chronic widespread pain.

AB - Background. Chronic widespread pain is the cardinal clinical feature of the fibromyalgia syndrome, which, in the majority of clinic patients, is persistent. By contrast, in community-derived patients, pain is persistent in only half of the affected individuals, particularly those with psychological distress. Whether such distress is a consequence of the pain or a manifestation of a wider process of somatization which is associated with the persistence of pain is unclear.Objectives. We tested in a large, prospective, population-based study thr hypothesis that features of somatization predict the persistence of chronic widespread pain.Methods. In all, 252 (13%) of 1953 adult subjects selected from a population register were classified as having chronic widespread pain based on a detailed questionnaire which included a pain drawing. Thr patients also completed a number of psychosocial instruments which measure features known to be associated with somatization. Two hundred and twenty-five (91%) of the patients were successfully followed up after 12 months and provided data on pain status using the same instruments.Results. In all, 126 (56%) patients reported chronic widespread pain at follow-up. 74 (33%) reported other pain acid 25 (11%) reported no pain. Persistent chronic widespread pain was strongly associated with baseline test scores for high psychological distress and fatigue. In addition, these subjects were more likely to display a pattern of illness behaviour characterized by frequent visits to medical practitioners for symptoms which disrupt daily activities. The prevalence of persistent pain increased with the number of risk factors the subjects were exposed to.Conclusions. Although almost half of the eases of chronic widespread pain resolved within 1 yr, this study has demonstrated for the first time that these subjects who display features of somatization are more likely to have widespread pain which persists. These findings have implications for the identification and treatment of poisons with persistent chronic widespread pain.

KW - chronic widespread pain

KW - persistence

KW - risk factors

KW - somatization

KW - SOMATIZATION DISORDER

KW - FIBROMYALGIA SYNDROME

KW - GENERAL-POPULATION

KW - PREVALENCE

KW - SCALES

U2 - 10.1093/rheumatology/40.1.95

DO - 10.1093/rheumatology/40.1.95

M3 - Editorial

VL - 40

SP - 95

EP - 101

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

ER -